Axitinib in advanced renal-cell carcinoma

Lancet Oncol. 2013 Dec;14(13):1245-6. doi: 10.1016/S1470-2045(13)70499-6. Epub 2013 Oct 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Axitinib
  • Carcinoma, Renal Cell / drug therapy*
  • Female
  • Humans
  • Imidazoles / therapeutic use*
  • Indazoles / therapeutic use*
  • Kidney Neoplasms / drug therapy*
  • Male
  • Niacinamide / analogs & derivatives*
  • Niacinamide / therapeutic use
  • Phenylurea Compounds / therapeutic use*
  • Sorafenib

Substances

  • Antineoplastic Agents
  • Imidazoles
  • Indazoles
  • Phenylurea Compounds
  • Niacinamide
  • Sorafenib
  • Axitinib